SUBSCRIBE
SUBSCRIBE

High-Level Medicare Part D Conference On The Ramifications For The Pharmaceutical Industry At The Corporate And Product Levels To Take Place April 25-26 In Washington, DC

October 19, 2005 | 
2 min read

WASHINGTON, Jan. 13 /PRNewswire/ -- The Medicare Prescription Drug, Improvement and Modernization Act is one of the most significant and complex pieces of legislation to be approved in nearly four decades. This bill affects a number of stakeholders, Medicare beneficiaries, managed care organizations (MCOs), pharmacy benefits managers (PBMs), state Medicaid programs, and physicians in many different ways.

Join Strategic Research Institute's "Medicare Part D: Ramifications for the Pharmaceutical Industry at the Corporate and Product Levels" conference scheduled to take place April 25-26, 2005 at the Westin Grand Hotel in Washington DC to hear how you can implement and develop Medicare related strategies for your organization.

The two day intensive information and networking extravaganza features senior-level executives from major pharmaceutical and biotech companies, health insurers, PBMs and other related healthcare organizations, to discuss the implementation of Medicare strategies to gain competitive advantage, the changing regulatory environment and most importantly the rising pharmaceutical costs. The conference agenda features case studies, panel discussions and keynotes. Some of the topics include:

   -- Impact of Part D Regions on Pharmaceutical Companies' Commercial
      Managed Care Business

   -- The Impact of Medicare Part D on State Medicaid Programs

   -- The Evolving Role of Health Economics and Outcomes Research Under
      Part D

   -- Implications for Pharmaceutical Field Sales

   -- Impact of the MMA on Interactions Between Account Managers and Managed
      Care Customers

   -- Compliance and Persistence in the Medicare Population

   -- Looking Down the Road: the Impact of Medicare Part D on Clinical
      Development Efforts

   -- Potential Impact of ePrescribing

   -- Key Strategies for Communicating with the Senior Market

   -- Market Research Needs in a New Competitive Landscape

   -- The Shifting Role of PBMs

   -- Segmentation of the Senior Market and Implications for Pharmaceutical
      Companies

   -- Physician Prescribing Habits

   -- The Future of Medicare: Possible Changes on the Horizon and How
      Pharmaceutical Companies Can Prepare

To be considered a speaker or panelist on any of the topics above or others immediately send your proposal to the organizer Mark Alexay at malexay@srinstitute.com or call 212.967.0095, ext 251.

To become a conference sponsor or exhibitor, please contact Mark Alexay at malexay@srinstitute.com or call 212.967.005, ext. 251

Anadys Pharmaceuticals, Inc. is a major sponsor at the event and will be sponsoring the cocktail reception on day one.

For more information on how to become a media partner, please contact Cheryl Kahan-Radhuber at ckahan-radhuber@srinstitute.com or call 212.967.0095, ext. 273

Strategic Research Institute

CONTACT: Mark Alexay, +1-212-967-0095, ext. 251,malexay@srinstitute.com, or Cheryl Kahan-Radhuber, +1-212-967-0095, ext. 273,ckahan-radhuber@srinstitute.com , both for Strategic Research Institute